Stock Research: Globus Medical

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Globus Medical

NYSE:GMED US3795772082
96
  • Value
    98
  • Growth
    59
  • Safety
    Safety
    48
  • Combined
    93
  • Sentiment
    76
  • 360° View
    360° View
    96
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Globus Medical, Inc. develops and commercializes healthcare solutions for musculoskeletal disorders. It operates in the medical device industry, specializing in spinal, orthopedic, and neurosurgical procedures. In the last fiscal year, the company had a market cap of $7,564 million, profits of $1,699 million, and revenue of $2,519 million, with 5300 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 96 (better than 96% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock Globus Medical are very positive. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for Globus Medical. The consolidated Growth Rank has a good rank of 59, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. This means that growth is higher than for 59% of competitors in the same industry. The consolidated Safety Rank at 98 means that the company has a financing structure that is safer than 98% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a good rank of 76, which means that professional investors are more optimistic about the stock than for 76% of alternative investment opportunities. But the consolidated Value Rank is less desirable at 48, meaning that the share price of Globus Medical is on the higher side compared with indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 52% of alternative stocks in the same industry. ...read more

more
Index
Robotics
D.J. US Medical Equipment
S&P MIDCAP
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Nov-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
48 31 69 47
Growth
59 95 71 63
Safety
Safety
98 19 95 95
Sentiment
76 78 26 40
360° View
360° View
96 37 57 44
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
38 45 19 28
Opinions Change
88 50 43 42
Pro Holdings
n/a 88 64 39
Market Pulse
79 63 23 93
Sentiment
76 78 26 40
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
48 31 69 47
Growth
59 95 71 63
Safety Safety
98 19 95 95
Combined
93 51 83 83
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
48 38 60 41
Price vs. Earnings (P/E)
40 33 56 45
Price vs. Book (P/B)
63 48 89 50
Dividend Yield
1 1 1 1
Value
48 31 69 47
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
46 42 100 37
Profit Growth
73 92 85 71
Capital Growth
37 96 37 45
Stock Returns
65 87 27 75
Growth
59 95 71 63
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
78 87 100 100
Refinancing
35 32 55 49
Liquidity
100 21 87 87
Safety Safety
98 19 95 95

Similar Stocks

Discover high‑ranked alternatives to Globus Medical and broaden your portfolio horizons.

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cigna

NYSE:CI
Country: USA
Industry: Health Care Services
Size: XX-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.